Investigational Site Number :2500016

Paris 75743

0 studies enrolling now · 2 studies all time

What they study most

Non-relapsing Secondary Progressive Multiple Sclerosis, Plasma Cell Myeloma

Studies at this site

• Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) — Completed
• Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients — Completed